Monokine-producing cells predominate in the recruitment phase of NOD insulitis while cells producing Th1-type cytokines characterize the effector phase

Journal of Autoimmunity

Volumn 10, Issue 2, 1997, Pages 147-155

  Pilström, Björn ^a   Björk, Lars ^a   Böhme, Jan ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

cytokines; immunofluorescence; insulitis; NOD mice; Th1

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 6; LYMPHOTOXIN; MONOKINE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL SUBPOPULATION; DIABETES MELLITUS; DISEASE COURSE; ENDOCRINE CELL; FLUORESCENCE MICROSCOPY; INFLAMMATORY CELL; INFLAMMATORY DISEASE; INSULITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031127355     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1996.0115     Document Type: Article

References (38)

1. 1. Kikutani H., Makino S. 1992. The murine autoimmune diabetes model: NOD and related strains. Adv. Immunol. 51: 285-322
2. 2. Allison J., Malcolm L., Chosich N., Miller J.F.A.P. 1992. Inflammation but not autoimmunity occurs in transgenic mice expressing constitutive levels of interleukin-2 in islet β cells. Eur. J. Immunol. 22: 1115-1121
3. 3. Higuchi Y., Herrera P., Muniesa P., Huarte J., Belin D., Ohashi P.S., Aichele P., Orci L., Vassalli J.-D., Vassalli P. 1992. Expression of a tumor necrosis factor α transgene in murine pancreatic β cells results in severe and permanent insulitis without evolution towards diabetes. J. Exp. Med. 176: 1719-1731
4. 4. Sarvetnick N., Liggitt D., Pitts S.L., Hansen S.E., Stewart T.A. 1988. Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma. Cell 52: 773-782
5. 5. Wogensen L., Lee M., Sarvetnick N. 1994. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of β cells in nonobese diabetic mice. J. Exp. Med. 179: 1379-1384
6. 6. Baquerizo H., Rabinovitch A. 1990. Interferon-gamma sensitizes rat pancreatic islet cells to lysis by cytokines and cytotoxic cells. J. Autoimmun. 3(Suppl.): 123-130
7. 7. Campbell I.L., Iscaro A., Harrison L.C. 1988. IFN-γ and tumor necrosis factor-α. Cytotoxicity to murine islets of Langerhans. J. Immunol. 141: 2325-2329
8. 8. Mandrup-Poulsen T., Bendtzen K., Dinarello C.A., Nerup J. 1987. Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic β-cell cytotoxicity. J. Immunol. 139: 4077-4082
9. 9. Rabinovitch A., Sumoski W., Rajotte R.V., Warnock G.L. 1990. Cytotoxic effects of cytokines on human pancreatic islet cells in monolayer culture. J. Clin. Endocrinol. Metab. 71: 152-156
10. 10. Campbell I.L., Kay T.W.H., Oxbrow L., Harrison L.C. 1991. Essential role for interferon-γ and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J. Clin. Invest. 87: 739-742
11. 11. Nicoletti F., Di Marco R., Barcellini W., Magro G., Schorlemmer H.U., Kurrle R., Lunetta M., Grasso S., Zaccone P., Meroni P.L. 1994. Protection from experimental autoimmune diabetes in non-obese diabetic mouse with soluble interleukin-1 receptor. Eur. J. Immunol. 24: 1843-1847
12. 12. Jacob C.O., Sadakazu A., Michie S.A., McDevitt H.O., Acha-Orbea H. 1990. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): Similarities between TNF-α and interleukin 1. Proc. Natl. Acad. Sci. 87: 968-972
13. 13. Campbell I.L., Oxbrow L., Harrison L.C. 1991. Reduction in insulin's following administration of IFN-γ and TNF-α in the NOD mouse. J. Autoimmun. 4: 249-262
14. 14. Satoh J., Seino H., Abo T., Tanaka S.-I., Shintani S., Ohta S., Tamura K., Sawai T., Nobunaga T., Oteki T., Kumagai K., Toyota T. 1989. Recombinant human tumor necrosis factor α suppresses autoimmune diabetes in nonobese diabetic mice. J. Clin. Invest. 84: 1345-1348
15. 15. Pennline K.J., Roque-Gaffney E., Monahan M. 1994. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin. Immunol. Immunopathol. 71: 169-175
16. 16. Yang X.-D., Tisch R., Singer S.M., Cao Z.A., Liblau R.S., Schreiber R.D., McDevitt H.O. 1994. Effect of tumor necrosis factor α on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process. J. Exp. Med. 180: 995-1004
17. 17. Shehadeh N.N., La Rosa F.G., Lafferty K.J. 1993. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J. Autoimmun. 6: 291-300
18. 18. Katz J.D., Benoist C., Mathis D. 1995. T helper cell subsets in insulin-dependent diabetes. Science 268: 1185-1188
19. 19. Trembleau S., Penna G., Bosi E., Mortara A., Gately M.K., Adorini L. 1995. Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J. Exp. Med. 181: 817-821
20. 20. Held W., McDonald H.R., Weissman I.L., Hess M.W., Mueller C. 1990. Genes encoding tumor necrosis factor α and granzyme A are expressed during development of autoimmune diabetes. Proc. Natl. Acad. Sci. 87: 2239-2243
21. 21. Toyoda H., Formby B., Magalong D., Redford A., Chan E., Takei S., Charles M.A. 1994. In situ islet cytokine gene expression during development of type I diabetes in the non-obese diabetic mouse. Immunol. Lett. 39: 283-288
22. 22. Jiang Z., Woda B.A. 1991. Cytokine gene expression in the islets of the diabetic BioBreeding/Worcester rat. J. Immunol. 146: 2990-2994
23. H1 mediated event. Autoimmunity 15: 113-122
24. 24. Lindsten T., June C.H., Ledbetter J.A., Stella G., Thompson C.B. 1989. Regulation of lymphokine messenger RNA stability by a surface mediated T cell activation pathway. Science 244: 339-342
25. H1 cytokine profile in the late phase of NOD insulitis. Cytokine 7: 806-814
26. 26. Sander B., Andersson J., Andersson U. 1991. Assessment of cytokines by immunofluorescence and the paraformaldehyde-saponin procedure. Immunol. Rev. 119: 65-93
27. 27. Sander B., Höidén I., Andersson U., Möller E., Abrams J.S. 1993. Similar frequencies and kinetics of cytokine producing cells in murine peripheral blood and spleen. Cytokine detection by immunoassay and intracellular immunostaining. J. Immunol. Methods 166: 201-214
28. 28. Signore A., Cooke A., Pozzilli P., Butcher G., Simpson E., Beverley P.C.L. 1987. Class-II and IL2 receptor positive cells in the pancreas of NOD mice. Diabetologia 30: 902-905
29. 29. Campbell I.L., Cutri A., Wilson A., Harrison L.C. 1989. Evidence for IL-6 production by and effects on the pancreatic β-cell. J. Immunol. 143: 1188-1191
30. 30. Höidén I., Cardell S., Möller G. 1993. Commitment to lymphokine profile during primary in vitro stimulation. Scand. J. Immunol. 38: 515-520
31. 31. van de Pouw-Kraan T., de Jong R., Arden L. 1993. Development of human Th1 and Th2 cytokine responses: the cytokine production profile of T cells is dictated by the primary in vitro stimulus. Eur. J. Immunol. 23: 1-5
32. 32. Andersson U., Andersson J., Lindfors A., Wagner K., Möller G., Heusser C.H. 1990. Simultaneous production of interleukin 2, interleukin 4, interferon-γ by activated human blood lymphocytes. Eur. J. Immunol. 20: 1591-1596
33. 33. Mandrup-Poulsen T., Zumsteg U., Reimers J.I., Pociot F., Mørch L., Helqvist S., Dinarello C.A., Nerup J. 1993. Involvement of interleukin 1 and interleukin 1 antagonist in pancreatic β-cell destruction in insulin-dependent diabetes mellitus. Cytokine 5: 185-191
34. 34. Rapoport M.J., Jaramillo A., Zipris D., Lazarus A.H., Serreze D.V., Leiter E.H., Cyopick P., Danska J.S., Delovitch T.L. 1993. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J. Exp. Med. 178: 87-99
35. 35. Allison J., Oxbrow L., Miller J.F.A.P. 1994. Consequences of in situ production of IL-2 for islet cell death. Int. Immunol. 6: 541-549
36. 36. Healey D., Ozegbe P., Arden S., Chandler P., Hutton J., Cooke A. 1995. In vivo activity and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice. J. Clin. Invest. 95: 2979-2985
37. 37. Rabinovitch A., Sorensen O., Suarez-Pinzon W.L., Power R.F., Rajotte R.V., Bleackley R.C. 1994. Analysis of cytokine mRNA expression in syngeneic islet grafts of NOD mice: interleukin 2 and interferon gamma mRNA expression correlate with graft rejection and interleukin 10 with graft survival. Diabetologia 37: 833-837
38. 38. Rothe H., Faust A., Schade U., Kleemann R., Bosse G., Hibino T., Martin S., Kolb H. 1994. Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not of interleukin-4. Diabetologia 37: 1154-1158